Serodase

Quick links to important sections

Serodase

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Serodase

Property Description
Active ingredient Serrapeptase (Serratiopeptidase)
Form Enteric Coated Tablet
Pharmacological class Proteolytic Enzyme, Systemic Anti-inflammatory Agent
Common use Managing Inflammation and Swelling
Origin Natural (bacterial fermentation)

What Type of Medicine is Serodase?

Serodase is a pharmaceutical preparation containing the primary active ingredient Serrapeptase, also known as Serratiopeptidase. This substance is categorized as a Proteolytic Enzyme and a Systemic Anti-inflammatory Agent. Serrapeptase is naturally derived from the Serratia species of bacteria and is manufactured through controlled fermentation technology. The formulation is typically presented as an enteric coated tablet for oral use. This specific dosage form is critical, as the coating protects the enzyme from being destroyed by the stomach's acid, ensuring its stability and full absorption for systemic action throughout the body.

Serrapeptase: Enzyme-Only vs. Combination Formulations

Serodase is available either as a single-ingredient medicine, containing only the Serratiopeptidase enzyme, or as a combination product (e.g., Serodase D). The combination formulation pairs the enzyme with a separate drug, such as the Non-steroidal Anti-inflammatory Drug (NSAID) Diclofenac (Diclofenac potassium). The single-ingredient version specifically targets the proteolytic enzyme action, while the combination offers a dual therapeutic approach. Other preparations sharing this core enzyme include common market alternatives such as Pepzen Tablet and Serrata Tablets.

General Purpose of the Proteolytic Action

The general therapeutic purpose of Serodase stems from its physiological action as a proteolytic enzyme: its ability to systematically break down specific types of non-living protein molecules. This function helps to clear inflammatory byproducts, such as fibrin and excess fluid, that often accumulate at injury sites, such as following surgical procedures or physical trauma. By assisting in the breakdown of these materials, Serodase generally facilitates the resolution of swelling and edema, thereby supporting the body’s natural process for tissue cleanup and the reduction of discomfort associated with inflammation.

What side effects are possible with Serodase?

Possible side effects and safety information

The safety profile for Serodase (Serrapeptase) is documented through regulatory channels by grouping possible adverse reactions into system-organ classes, with specific focus on both common and rare events, as well as constraints for certain patient populations. The frequency of many effects is often classified as not defined across global regulatory documents.

Adverse reactions are primarily observed in the Gastrointestinal System, including nausea, vomiting, diarrhea, stomach discomfort, and loss of appetite. Reactions concerning the Skin and Subcutaneous Tissue are also documented, such as skin rash and hypersensitivity.

Serious Adverse Reactions

Official safety documentation highlights rare but clinically significant reactions. These include reports of Eosinophilic Pneumonitis (lung inflammation) and severe cutaneous adverse reactions such as Stevens-Johnson Syndrome. Furthermore, the enzyme's mechanism is associated with a risk of blood clotting disturbances and, rarely, serious hemorrhage, which is classified under Blood and Lymphatic System Disorders.

Safety Constraints and Specific Populations

The safety profile includes restrictions for certain groups. The use of Serodase is generally avoided during pregnancy and lactation due to a lack of established safety data. Explicit caution is necessary for individuals with a history of peptic ulcers or existing bleeding disorders. Due to its potential to interfere with coagulation, regulatory notes specify that the medicine should be discontinued prior to scheduled surgical procedures.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for an overdose of Serodase (Serrapeptase) as a single-ingredient preparation does not consistently describe a specific, defined acute toxic syndrome. Official regulatory documentation emphasizes emergency action and supportive care rather than a unique set of manifestations.

Documented Overdose Manifestations and Risks

Feature Regulatory Statement
Documented Manifestations No specific acute toxic syndrome is defined; concerns relate to the exacerbation of known systemic adverse effects.
Potential Severe Outcomes Risk includes severe hypersensitivity reactions (e.g., difficulty breathing) and the theoretical magnification of bleeding risk at very high levels.

Required Emergency Actions

Immediate medical attention or contacting emergency services is mandated if ingestion significantly exceeding the recommended dose is suspected, or if any severe symptoms, such as signs of a systemic allergic reaction, occur.

Management, as described in official prescribing information, is restricted to symptomatic and supportive treatment. No specific antidote for Serrapeptase overdose is known or documented. Hospital observation and monitoring of vital signs may be required until the patient’s condition stabilizes, particularly to monitor for severe or delayed systemic reactions.

Therapeutic Uses of Serodase

Quick Facts

Therapeutic Domain Primary Use
Inflammation May assist in reducing swelling
Pain Used in the management of pain
Recovery Supports recovery from surgical procedures or injury

What Serodase Treats: Main Uses and Benefits

Serodase is a preparation that contains the enzyme serratiopeptidase, which is studied for its use in managing symptoms related to inflammation. It is generally recognized as a treatment option in several countries, particularly for its potential to affect swelling and pain.

This preparation is often used to support the management of conditions where inflammation is a key factor. Clinical experience suggests it may assist in reducing localized swelling and related discomfort following trauma or surgical procedures. Its therapeutic application also extends to relieving the symptoms associated with certain chronic inflammatory conditions, such as some types of joint discomfort and respiratory issues like sinusitis or bronchitis.

Management with this medication is intended to support the body’s natural response to inflammation and may contribute to a more comfortable recovery process. The healthcare provider will determine if this preparation is appropriate for a patient’s specific needs.

Eligibility and Restrictions for Use

Official Eligibility and Contraindication Profile

Serodase (typically containing diclofenac and serratiopeptidase) is contraindicated and must not be used by specific patient groups, primarily due to the NSAID component. Absolute contraindications include known hypersensitivity to any component of the medicine or other NSAIDs (e.g., aspirin), active gastrointestinal ulceration, bleeding, or perforation, and pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Use is also contraindicated in patients with established severe cardiovascular disease, such as congestive heart failure (NYHA class II-IV), ischemic heart disease, or cerebrovascular disease, as stated by regulatory bodies.

Restricted and Special Populations

Population Group Regulatory Status
Pregnancy Contraindicated in the third trimester; not recommended otherwise.
Breastfeeding Not recommended due to lack of established safety data.
Pediatrics Use is not established or generally not indicated in children.
Organ Impairment Restricted use or caution required for severe renal or hepatic impairment.
Older Adults Use requires caution due to increased risk of serious adverse effects, including kidney failure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction profile for Serodase (Serrapeptase), based on authoritative government health guidance and drug monographs.


Interaction Scope

Property Official Regulatory Information
Medicinal Product Categories with Documented Interactions Medications that slow blood clotting (Anticoagulants or Antiplatelet drugs) and Anti-inflammatory medications.
Specific Interacting Medicines Examples cited in the regulatory context include Warfarin, Heparin, and Aspirin.
Mechanistic Basis of Interactions Classified as a pharmacodynamic additive effect that may increase the risk of bruising or bleeding.
Timing-Based Interaction Rules Requires use to be discontinued at least two weeks before any scheduled surgical procedure.
Population-Specific Interaction Notes Caution is advised for patients with pre-existing bleeding disorders and when combined with anticoagulants in pediatric and geriatric populations.

Interaction Classification

Classification Official Regulatory Information
Interaction Severity Classified as a Caution or Requires Consultation. It is not listed as a formal, absolute contraindication.
Interaction-Related Restrictions Consultation with a healthcare professional is required before use if a patient is currently taking blood thinners or anti-inflammatory medicines.

Resulting Interaction Structure

Official interaction statements:

  • Pharmacodynamic Interaction: Official regulatory guidance advises caution with co-administration of medications that slow blood clotting due to a documented additive effect.
  • Procedural Restriction: The prescribing context requires the medicine to be stopped a minimum of 2 weeks before any scheduled surgery.
  • Absence of Pharmacokinetic Interactions: No official regulatory information documents interactions involving drug metabolism (CYP enzymes), drug transporters, or formal changes to drug exposure or clearance.

Connection to the overall interaction profile (2–4 sentences):

The regulatory profile is primarily defined by the pharmacodynamic risk of additive effects with blood-thinning agents and anti-inflammatory medicines. This effect mandates a crucial timing restriction requiring cessation of the medicine before any scheduled surgical procedure. The official profile is further characterized by the absence of documented metabolic or transporter-mediated pharmacokinetic interactions.

Mechanism of Action

How Serodase Works

Serodase's mechanism of action is defined by its core activity as a systemic enzyme that targets and modifies both the physical components and the biochemical mediators involved in the inflammatory response.


Targeted Enzymatic Action and Physical Clearance

This domain covers the primary biological function of the active enzyme, Serrapeptase. As a Serine Protease, the molecule exerts proteolytic hydrolysis by selectively breaking down non-viable proteinaceous debris, notably Fibrin, and other components of inflammatory exudates . By facilitating the degradation and clearance of these materials, the mechanism directly addresses the buildup of pressure and fluid, resulting in the reduction of extravascular fluid accumulation and tissue turgidity.


Modulation of Inflammatory Signaling Cascades

The enzyme also acts within the Kallikrein-Kinin system by cleaving the peptide Bradykinin, thereby reducing its concentration in local tissues. Furthermore, it exerts a modulatory influence on the Arachidonic Acid Cascade, specifically dampening the activity of Cyclooxygenase (COX) enzymes . This dual action on key inflammatory mediators reduces the chemical stimulation of nociceptive fibers, contributing to a systematic dampening of nociceptive signaling.


Dual Mechanism in Combination Formulations

In products containing both Serrapeptase and an NSAID like Diclofenac, the drug engages a complementary, non-redundant mechanism. Serrapeptase handles the physical clearance of accumulated protein and fluid, while the NSAID component provides direct inhibition of Prostaglandin synthesis. This combined action ensures the simultaneous modulation of both structural protein deposits and the underlying biochemical signaling cascades.

Dosage and Administration Information

How to Use Serodase: Administration Guidelines

Serodase, a preparation containing the enzyme Serrapeptase, is formulated exclusively for oral administration and must be used according to specific instructions to maintain the enzyme’s activity and ensure its proper absorption.


Administration Scope

Instruction Usage Principle
Route of Administration Oral only.
Dosing Schedule The standard adult regimen typically utilizes a total daily dose between 30 mg and 60 mg (or 60,000 to 120,000 Serrapeptase Units [SU]).
Timing Relative to Meals Must be taken on an empty stomach. This typically requires administration 30 minutes before a meal or 2 hours after a meal.
Form Integrity The enteric-coated tablet or capsule must be swallowed whole with water. It is essential not to crush, split, or chew the preparation.

Usage Patterns and Restrictions

Usage of this enzyme preparation is generally intended for short-term courses. For instance, use related to inflammation or swelling management is often restricted to up to seven days without further consultation. The standard daily intake is typically achieved through divided doses, commonly administered three times per day.

The dosage regimens are established for the adult population (18 years and older). Prescribing information generally advises against use in pediatric patients due to a lack of established safety and efficacy data.

Recent Clinical Evidence

Serodase, which contains the proteolytic enzyme serrapeptase (also known as serratiopeptidase), has been studied for its anti-inflammatory, anti-edemic (swelling reduction), and analgesic (pain relief) properties. Clinical evidence for its use has been evaluated across various conditions, primarily focusing on its ability to reduce inflammation and swelling following trauma or surgical procedures.

Efficacy and Therapeutic Use

  • Post-Operative Swelling: Several randomized controlled trials have investigated serrapeptase's role in reducing swelling and pain after surgical procedures, particularly in dental surgery (e.g., wisdom tooth removal). Some studies suggest it is effective in reducing post-operative facial swelling and lockjaw (trismus) compared to a placebo or certain conventional anti-inflammatory drugs, though results for pain relief have been mixed.
  • Traumatic Injury: A small body of evidence indicates serrapeptase may be effective in reducing edema (swelling) in acute injuries such as ankle sprains. In some comparative studies, it demonstrated a superior effect on swelling reduction compared to paracetamol (acetaminophen).
  • Mucolytic Action: Serrapeptase has been investigated for its potential to reduce the viscosity of mucus in respiratory and ear, nose, and throat (ENT) conditions. Early research suggests it may help alleviate symptoms like pain, nasal obstruction, and secretions in conditions such as sinusitis and laryngitis, although evidence remains limited.

Limitations and Safety Profile

Overall, comprehensive systematic reviews and meta-analyses often conclude that while initial findings show promise, the existing clinical evidence for serrapeptase is insufficient or inconsistent due to methodological weaknesses, small sample sizes, and a lack of proper controls in many trials. Its use in many listed conditions is not yet supported by a strong, high-quality evidence base.

Regarding safety, serrapeptase is generally reported to be well-tolerated in short-term use (up to four weeks). Reported side effects are typically mild, including nausea and stomach upset. However, long-term safety data are currently lacking. Caution is advised for individuals with bleeding disorders or those taking anticoagulant/antiplatelet medications, as serrapeptase may interfere with normal blood clotting.

Frequently Asked Questions (FAQ)

Common questions about Serodase (FAQ)


Q: Is Serodase a pain reliever?

A: Official research suggests Serodase has analgesic (pain-relieving) properties, potentially by influencing certain chemical signals related to discomfort. However, clinical studies focused on pain relief often report mixed or inconsistent findings when compared to its documented effects on swelling.


Q: What happens if I stop taking Serodase suddenly?

A: Official regulatory guidance advises discontinuing Serodase if issues such as gastrointestinal side effects occur or if the condition being treated persists or worsens. The official product information does not specify negative health consequences related to suddenly stopping the medicine.


Q: Can Serodase be taken with over-the-counter cold medicines?

A: Official safety documents advise caution when combining Serodase with other anti-inflammatory medicines or drugs that slow blood clotting. Checking the active ingredients of any over-the-counter cold or flu product is advised to identify potential interacting components.


Q: What is the difference between Serodase and other similar drugs I've heard of?

A: Serodase is classified as a proteolytic enzyme that reduces swelling by breaking down protein deposits and fluid that accumulate during inflammation. This mechanism is distinct from common anti-inflammatory drugs (NSAIDs), which primarily work by blocking chemical pathways. Some Serodase formulations are combination products that include an NSAID to provide a dual therapeutic effect.


Q: Is it normal to feel a little dizzy after starting Serodase?

A: Official safety information includes dizziness and drowsiness as possible adverse effects that may be experienced by some patients. Regulatory guidance advises caution with activities like driving or operating machinery while taking this medicine, as the effects can vary among individuals.


Q: Are there any known interactions between Serodase and alcohol?

A: Official product warnings advise that alcohol consumption should be avoided while using Serodase. This caution is typically due to the potential for an increased risk of adverse effects, including a possible risk to the liver, especially when the formulation contains a non-steroidal anti-inflammatory drug (NSAID) component.


Q: Is Serodase safe to use long-term?

A: The documented use of Serodase is generally intended for short-term courses, often limited to a few weeks. Regulatory safety reviews indicate that comprehensive data on the safety and effects of using Serodase for extended long-term periods are currently lacking.


Q: Is Serodase a prescription-only medicine?

A: The regulatory status of Serodase differs based on the country and the specific product formulation. In some places, the core enzyme is sold as a dietary supplement, while in others, particularly when it is formulated with other active prescription drugs, it is classified as a prescription-only medicine.


Q: Why is Serodase taken with a full glass of water?

A: Official administration instructions require that the enteric-coated tablet be swallowed whole with water. This method ensures the enzyme is protected from stomach acid and helps the tablet pass easily for systemic absorption in the intestines.


Q: Can Serodase affect my ability to drive or operate machinery?

A: Official regulatory information advises caution regarding driving and operating heavy machinery. This is because possible adverse effects such as dizziness or drowsiness could affect coordination or reaction time.


Q: Is Serodase similar to a steroid?

A: Serodase is classified pharmacologically as a proteolytic enzyme with systemic anti-inflammatory properties. It is structurally and chemically distinct from corticosteroid medicines, which belong to a different drug class with a different mechanism of action.


Q: Can Serodase interact with herbal supplements?

A: Regulatory guidance advises caution when combining Serodase with products that may slow blood clotting, as this could increase the risk of bruising or bleeding. Checking if any accompanying herbal or dietary supplements are known to have a blood-thinning effect is important.


Q: What is the shelf life of Serodase?

A: Like all pharmaceutical products, Serodase has a specific shelf life, and an expiration date is clearly printed on the packaging. To maintain the enzyme's integrity, the medicine must be stored correctly and safely discarded once the expiration date has passed.


Q: What is the 'mechanism of action' of Serodase in simple terms?

A: In simple terms, Serodase is an enzyme designed to break down specific, non-living protein molecules and excess fluid that accumulate during the inflammatory process. This mechanism is thought to assist in the resolution of swelling (edema).


Q: What if Serodase doesn't seem to be working after a week?

A: Official regulatory guidance advises that if symptoms persist, worsen, or change despite using Serodase, the product should be discontinued. In these circumstances, consulting a healthcare practitioner is recommended.


Q: Are allergic reactions to Serodase common?

A: Official safety documents list hypersensitivity (allergic) and skin reactions as possible adverse effects of Serodase. However, the specific frequency of these reactions is often categorized as unknown or not defined in the available regulatory data.


Q: Does Serodase affect blood pressure?

A: Official regulatory information indicates that Serodase (particularly when combined with an NSAID) is cautioned or contraindicated for use in patients with high blood pressure (hypertension) or severe cardiovascular disease. Its use may be associated with risk in these pre-existing conditions.


Q: How does Serodase compare to other treatments for the same condition, based on available evidence?

A: Studies have compared Serodase to placebo, paracetamol (acetaminophen), and certain conventional anti-inflammatory drugs. Evidence indicates Serodase may be effective for reducing swelling (edema) after specific surgeries and injuries, and some studies suggest a difference in effect compared to paracetamol in this regard, though overall results for pain relief have been mixed.


Q: Can I take Serodase with other prescription drugs that cause drowsiness?

A: Since Serodase has been associated with effects like drowsiness and dizziness in some safety documents, caution is generally advised when combined with other prescription medications that can also cause similar central nervous system effects.


How should Serodase be stored and disposed of?

The storage and disposal of Serodase (Serrapeptase) must adhere strictly to official regulatory guidelines to preserve the stability of the enteric-coated enzyme tablet and ensure safety.

Storage Requirements

The product must be stored below 30 C or at controlled room temperature, in a cool and dry place. The tablets must be protected from direct heat, moisture, and light. To maintain integrity, the medicine should be kept in its original container and the container must remain tightly closed.

For household safety, Serodase must always be stored out of the sight and reach of children.

Disposal Instructions

Any unused or expired Serodase must be disposed of safely according to local regulations. If an official medicine take-back program is unavailable, general guidance recommends mixing the unneeded tablets with an undesirable substance, sealing the mixture, and discarding it in the trash, while avoiding flushing them down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Serodase found in:

A-Z Index: